Can 'Virafin' be a viable alternative for Remdesivir as COVID-19 wreaks havoc in India
The price of the drug is yet to be decided but it will be positioned competitively against Remdesivir
Apr 24, 2021, 13:39 PM IST
DNA: Virafin, a hope to eradicate COVID-19
Zydus Cadila on Friday received approval from the Drug Controller General of India (DGCI) for emergency use of the drug Virafin. Antiviral Virafin will reportedly make treatment more convenient for COVID-19 patients.
Apr 23, 2021, 22:00 PM IST
Emergency use of Zydus Cadila's drug Virafin approved against COVID-19
To speed up the treatment of Coronavirus patients, the Drug Controller General of India (DGCI) on Friday approved the emergency use of Zydus Cadila's drug Virafin. This medicine can be used to treat patients above 18 years of age.
Apr 23, 2021, 17:02 PM IST
Breaking news: DGCI approves emergency use of Zydus Cadila's Virafin for moderate COVID-19 infection
Drugs Controller General of India, DGCI, on Friday (April 23) approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
Apr 23, 2021, 15:53 PM IST
